A complete vaccination process is an important part of rabies prevention after cat-related injuries. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides Cat Bite Rabies Vaccine With Complete Vaccination Schedule as a professional rabies vaccine solution for medical institutions and healthcare partners requiring standardized post-exposure protection procedures. As an experienced rabies vaccine supplier, AIM Honor focuses on Vero cell vaccine technology, production quality, and stable supply capability.
After a cat bite or scratch, vaccination alone is not the only important step. A complete rabies prevention procedure includes immediate wound treatment, exposure evaluation, vaccine administration according to schedule, and completion of all required doses. Proper management helps support the development of protective antibodies after possible exposure.
AIM Honor provides conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine options. These products are developed to meet professional medical application needs and support standardized rabies prevention programs.
The vaccination schedule after cat-related exposure should follow professional medical evaluation and recommended procedures. Completing the full vaccination course is important because interrupted vaccination may affect the establishment of effective immune protection.
A standardized response process usually includes the following important stages:
1. Immediate wound treatment: Clean the wound with soap water or clean water for more than 15 minutes, then disinfect according to professional recommendations.
2. Exposure assessment: Healthcare professionals evaluate the injury type, wound condition, and animal information to determine the appropriate prevention approach.
3. Vaccination initiation: Start vaccination according to medical recommendations after exposure evaluation.
4. Schedule completion: Complete all required vaccine doses according to the recommended timetable to support immune response development.
Cat bite exposure requires attention to vaccination timing. According to the provided product information, the commonly used intramuscular vaccination schedule for Category II and Category III exposure includes five doses on days 0, 3, 7, 14, and 28.
| Vaccination Time | Procedure | Purpose |
|---|---|---|
| Day 0 | First vaccination dose | Begin immune response activation after exposure |
| Day 3 | Second vaccination dose | Continue immune system stimulation |
| Day 7 | Third vaccination dose | Support antibody development process |
| Day 14 | Fourth vaccination dose | Strengthen immune protection response |
| Day 28 | Fifth vaccination dose | Complete the standard vaccination course |
Rabies vaccination requires a complete course because the immune system needs appropriate stimulation over time. Following the recommended schedule helps healthcare providers manage post-exposure prevention more effectively.
1. Consistent immune stimulation: Multiple doses support continuous immune response development.
2. Better vaccination management: A clear timetable helps patients and healthcare providers track vaccination progress.
3. Standardized prevention: Completing the recommended course supports professional rabies prevention procedures.
Cat-related injuries can happen in different situations, including household pet accidents, stray cat encounters, and animal-related work environments. Proper exposure management helps reduce risks and supports timely medical intervention.
1. Pet cat bites: Even domestic cats may require professional assessment when bites break the skin or when vaccination status is uncertain.
2. Stray cat injuries: Stray or unknown-status cats require special attention because the animal health condition may not be confirmed.
3. Multiple exposure environments: Animal handlers and veterinary professionals may require awareness of rabies prevention procedures due to frequent animal contact.
A complete vaccination schedule requires reliable vaccine products supported by professional manufacturing technology. AIM Honor develops rabies vaccine solutions based on Vero cell culture technology, providing conventional and serum-free options for different healthcare requirements.
Vero cell culture technology is an important production platform used in biological product manufacturing. AIM Honor applies this technology to rabies vaccine development and production, focusing on product consistency, safety management, and immune response performance.
According to the provided product information, the conventional rabies vaccine uses the indigenous aG strain, while the serum-free Vero cell rabies vaccine uses the PV-2061 strain. Both solutions are designed to support professional rabies prevention after possible exposure.
The effectiveness of a vaccination program depends on both product quality and completion of the recommended vaccination procedure. AIM Honor’s vaccine products are developed with high immunogenicity characteristics to support antibody production after vaccination.
According to the provided product data, the seroconversion rate reaches 100% at 14 days after vaccination, and the neutralizing antibody level exceeds the WHO protective threshold of 0.5IU/ml.
1. Immune activation: Vaccination stimulates the immune system to recognize rabies virus components and develop protective antibodies.
2. Protection development: Completing the vaccination schedule supports the formation of effective immune protection.
3. Professional guidance: Healthcare professionals evaluate exposure conditions and provide appropriate vaccination recommendations.
For hospitals, CDC organizations, distributors, and healthcare partners, understanding product specifications is important when selecting a rabies vaccine supplier. The following information is based on the product materials provided by AIM Honor.
| Parameter | Conventional Vero Cell Rabies Vaccine | Serum-Free Vero Cell Rabies Vaccine |
|---|---|---|
| Vaccine Type | Inactivated rabies vaccine | Inactivated rabies vaccine |
| Production Method | Vero cell culture technology | Serum-free Vero cell culture technology |
| Virus Strain | Indigenous aG strain | PV-2061 strain |
| Application Purpose | Post-exposure rabies prevention | Post-exposure rabies prevention with serum-free process |
| Seroconversion Rate | 100% at 14 days after vaccination according to provided information | 100% at 14 days after vaccination according to provided information |
| Antibody Level | Exceeds WHO protective threshold of 0.5IU/ml | Exceeds WHO protective threshold of 0.5IU/ml |
| Special Feature | No preservatives added | Serum-free production process throughout manufacturing |
AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on pharmaceutical quality management throughout research, production, and supply. The company provides professional rabies prevention solutions based on standardized manufacturing processes and technical experience.
Reliable vaccine production requires strict management of raw materials, production procedures, and quality evaluation. AIM Honor follows professional pharmaceutical manufacturing practices to support product reliability.
1. Process management: Standardized production procedures are applied throughout vaccine manufacturing.
2. Quality evaluation: Products undergo quality assessment before supply according to pharmaceutical requirements.
3. Continuous improvement: AIM Honor continues to optimize technology and manufacturing capability to support healthcare needs.
According to the provided company information, the conventional rabies vaccine has obtained National Drug Approval Number S20073014 and maintained a 100% batch release qualification rate for 17 years.
The serum-free Vero cell rabies vaccine has completed Phase III clinical trials, and the marketing authorization application has been accepted by the Center for Drug Evaluation (CDE). The production process complies with WHO Specifications for the Use of Biological Products Raw Materials.
For professional buyers, vaccine procurement involves more than product selection. Stable supply capability, technical support, and manufacturing experience are also important factors when choosing a long-term partner.
AIM Honor provides cooperation support for customers requiring Cat Bite Rabies Vaccine With Complete Vaccination Schedule, helping healthcare organizations establish reliable rabies prevention solutions.
1. Stable supply experience: AIM Honor products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China.
2. Product selection flexibility: Customers can select conventional Vero cell rabies vaccine or serum-free Vero cell rabies vaccine according to application requirements.
3. Professional cooperation: AIM Honor provides product communication and cooperation support for healthcare partners and distributors.
AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on biological pharmaceutical development and vaccine manufacturing. With professional experience in rabies vaccine production, the company provides reliable solutions for healthcare institutions, distributors, and professional partners.
For organizations searching for Cat Bite Rabies Vaccine With Complete Vaccination Schedule, AIM Honor combines vaccine technology, manufacturing capability, and supply experience to support different rabies prevention programs.
AIM Honor continues to improve vaccine production technology and quality management systems. The company provides both conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine solutions to meet different market requirements.
According to the provided company information, AIM Honor vaccine products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China, demonstrating practical experience in vaccine application and supply management.
AIM Honor supports cooperation with international customers by providing professional product information and communication services. The company works with healthcare-related organizations to contribute to global rabies prevention and control.
1. Distributor cooperation: Support professional partners requiring stable rabies vaccine products and cooperation solutions.
2. Medical institution support: Provide product information for hospitals, clinics, and healthcare organizations.
3. Long-term partnership: Focus on building reliable cooperation through professional service and stable supply capability.
A: Completing the vaccination schedule helps support continuous immune response development after possible rabies exposure. The recommended vaccination procedure allows the immune system to receive appropriate stimulation over time and helps healthcare professionals manage post-exposure prevention more effectively.
A: According to the provided product information, the commonly used intramuscular vaccination schedule for Category II and Category III exposure includes doses on days 0, 3, 7, 14, and 28. The final vaccination plan should be determined by healthcare professionals according to individual exposure conditions.
A: Yes. Immediate wound cleaning is an important part of rabies prevention after cat-related injuries. The wound should be washed with soap water or clean water for more than 15 minutes and disinfected according to professional recommendations before receiving medical evaluation.
A: Yes. AIM Honor provides Vero cell rabies vaccine solutions, including conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine. These products are developed for professional rabies prevention applications.
A: The conventional vaccine uses the indigenous aG strain and the serum-free vaccine uses the PV-2061 strain. The serum-free product adopts a serum-free culture process throughout manufacturing, while both products focus on supporting effective rabies prevention.
A: AIM Honor products are suitable for professional buyers including medical institutions, CDC organizations, distributors, and healthcare-related partners requiring reliable rabies prevention solutions.
A complete rabies prevention process requires timely wound management, professional exposure evaluation, and following the recommended vaccination procedure. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides professional vaccine solutions supported by Vero cell technology, standardized manufacturing, and long-term supply experience.
For healthcare organizations and professional buyers looking for Cat Bite Rabies Vaccine With Complete Vaccination Schedule, AIM Honor offers reliable products and cooperation support. Through continuous improvement in vaccine technology and quality management, the company contributes to stronger rabies prevention systems worldwide.